Jorge G Rossi
Overview
Explore the profile of Jorge G Rossi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
164
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mitchell M, Urdinez L, Bernasconi A, Danielian S, Katsikas M, Sajaroff E, et al.
J Clin Immunol
. 2024 May;
44(6):138.
PMID: 38805138
Background: Inborn Errors of Immunity (IEI) comprise several genetic anomalies that affect different components of the innate and adaptive responses, predisposing to infectious diseases, autoimmunity and malignancy. Different studies, mostly...
2.
Rizzo A, Sanz M, Roffe G, Sajaroff E, Prado D, Prieto E, et al.
Cytometry B Clin Cytom
. 2024 May;
106(5):383-391.
PMID: 38770762
X-linked inhibitor of apoptosis (XIAP) deficiency is an infrequent inborn error of immunity caused by mutations in XIAP gene. Most cases present with absence of XIAP protein which can be...
3.
Pennella C, Cassina T, Rossi J, Baialardo E, Rubio P, Deu M, et al.
Cancers (Basel)
. 2022 Jul;
14(13).
PMID: 35805057
Children with Down syndrome (DS) are at an increased risk of developing clonal myeloproliferative disorders. The balance between treatment intensity and treatment-related toxicity has not yet been defined. We analyzed...
4.
Wodlinger M, Reiter M, Weijler L, Maurer-Granofszky M, Schumich A, Sajaroff E, et al.
Comput Biol Med
. 2022 Mar;
144:105314.
PMID: 35247762
Acute Lymphoblastic Leukemia (ALL) is the most frequent hematologic malignancy in children and adolescents. A strong prognostic factor in ALL is given by the Minimal Residual Disease (MRD), which is...
5.
Pennella C, Deu M, Rossi J, Baialardo E, Alonso C, Rubio P, et al.
Pediatr Blood Cancer
. 2020 Jul;
67(10):e28624.
PMID: 32729239
Background: Infant acute lymphoblastic leukemia (ALL) is an infrequent disease characterized by clinical and biological features related to poor prognosis. Adapted therapies were designed without a clear consensus regarding the...
6.
Reiter M, Diem M, Schumich A, Maurer-Granofszky M, Karawajew L, Rossi J, et al.
Cytometry A
. 2019 Jul;
95(9):966-975.
PMID: 31282025
Minimal residual disease (MRD) as measured by multiparameter flow cytometry (FCM) is an independent and strong prognostic factor in B-cell acute lymphoblastic leukemia (B-ALL). However, reliable flow cytometric detection of...
7.
Peruzzo L, Bertone M, Mathey M, Rossi J, Baialardo E, Felice M
Medicina (B Aires)
. 2019 Jan;
79(1):1-5.
PMID: 30694182
Acute leukemia is the most frequent malignant disease in childhood. Acute lymphoblastic leukemia represents 75% and acute myeloblastic leukemia 25% of them. Erythroleukemia is a rare entity, corresponding to less...
8.
Bernasconi A, Yancoski J, Villa M, Oleastro M, Galicchio M, Rossi J
J Clin Immunol
. 2018 Oct;
38(7):745-747.
PMID: 30302727
No abstract available.
9.
Pennella C, Rossi J, Baialardo E, Alonso C, Guitter M, La Rosa C, et al.
Arch Argent Pediatr
. 2018 Jul;
116(4):e500-e507.
PMID: 30016023
Introduction: Children with Down syndrome (DS) more commonly have acute lymphoblastic leukemia (ALL) and a lower survival rate than those without Down syndrome (WDS). We analyzed the clinical, demographic, and...
10.
Felice M, Rossi J, Alonso C, Rubio P, Gallego M, Galluzzo M, et al.
J Pediatr Hematol Oncol
. 2017 Sep;
39(8):e406-e412.
PMID: 28945661
Introduction: Childhood acute leukemias (AL) and lymphomas achieve good survival rates. However, second neoplasms (SN) are a devastating event. Methods: From August 1987 to December 2016, 34 of 3321 (1%)...